利妥昔单抗治疗特发性硬化性肠系炎成功的首次报道。

IF 0.6 Q3 MEDICINE, GENERAL & INTERNAL

Journal of Community Hospital Internal Medicine Perspectives Pub Date : 2025-07-03 eCollection Date: 2025-01-01 DOI:10.55729/2000-9666.1504

Indira Acharya, Carey Field, Mary E Clark

{"title":"利妥昔单抗治疗特发性硬化性肠系炎成功的首次报道。","authors":"Indira Acharya, Carey Field, Mary E Clark","doi":"10.55729/2000-9666.1504","DOIUrl":null,"url":null,"abstract":"Sclerosing mesenteritis (SM) is a rare idiopathic fibroinflammatory disorder of the bowel mesentery adipose tissue. While the use of rituximab has been documented in IgG4-related SM, its effectiveness in idiopathic, IgG4-unrelated SM remains unknown. We present a case of idiopathic SM successfully managed with rituximab, suggesting that this treatment may be an option for patients who either have contraindications to or have not responded to current first-line therapies.","PeriodicalId":15460,"journal":{"name":"Journal of Community Hospital Internal Medicine Perspectives","volume":"15 4","pages":"100-103"},"PeriodicalIF":0.6000,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12315893/pdf/","citationCount":"0","resultStr":"{\"title\":\"First Report of Successful Rituximab Therapy in Idiopathic Sclerosing Mesenteritis.\",\"authors\":\"Indira Acharya, Carey Field, Mary E Clark\",\"doi\":\"10.55729/2000-9666.1504\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Sclerosing mesenteritis (SM) is a rare idiopathic fibroinflammatory disorder of the bowel mesentery adipose tissue. While the use of rituximab has been documented in IgG4-related SM, its effectiveness in idiopathic, IgG4-unrelated SM remains unknown. We present a case of idiopathic SM successfully managed with rituximab, suggesting that this treatment may be an option for patients who either have contraindications to or have not responded to current first-line therapies.\",\"PeriodicalId\":15460,\"journal\":{\"name\":\"Journal of Community Hospital Internal Medicine Perspectives\",\"volume\":\"15 4\",\"pages\":\"100-103\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2025-07-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12315893/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Community Hospital Internal Medicine Perspectives\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.55729/2000-9666.1504\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Community Hospital Internal Medicine Perspectives","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55729/2000-9666.1504","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

摘要

硬化性肠系膜炎（SM）是一种罕见的肠肠系膜脂肪组织的特发性纤维炎性疾病。虽然在igg4相关的SM中有使用利妥昔单抗的记录，但其在特发性、igg4无关的SM中的有效性仍然未知。我们报告了一例特发性SM成功地用利妥昔单抗治疗，这表明这种治疗可能是对目前一线治疗有禁忌症或无反应的患者的一种选择。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

First Report of Successful Rituximab Therapy in Idiopathic Sclerosing Mesenteritis.

查看原文本刊更多论文

First Report of Successful Rituximab Therapy in Idiopathic Sclerosing Mesenteritis.

Sclerosing mesenteritis (SM) is a rare idiopathic fibroinflammatory disorder of the bowel mesentery adipose tissue. While the use of rituximab has been documented in IgG4-related SM, its effectiveness in idiopathic, IgG4-unrelated SM remains unknown. We present a case of idiopathic SM successfully managed with rituximab, suggesting that this treatment may be an option for patients who either have contraindications to or have not responded to current first-line therapies.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Community Hospital Internal Medicine Perspectives MEDICINE, GENERAL & INTERNAL-

自引率

0.00%

发文量

106

审稿时长

17 weeks

期刊介绍： JCHIMP provides: up-to-date information in the field of Internal Medicine to community hospital medical professionals a platform for clinical faculty, residents, and medical students to publish research relevant to community hospital programs. Manuscripts that explore aspects of medicine at community hospitals welcome, including but not limited to: the best practices of community academic programs community hospital-based research opinion and insight from community hospital leadership and faculty the scholarly work of residents and medical students affiliated with community hospitals.